HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Enhancement of the toxicity and DNA incorporation of arabinosyl-5-azacytosine and 1-beta-D-arabinofuranosylcytosine by cyclopentenyl cytosine.

Abstract
We evaluated the interaction of a biochemically active concentration of cyclopentenyl cytosine (CPE-C), an investigational antimetabolite which inhibits CTP synthetase, on the cytotoxicity of arabinosyl-5-azacytosine (Ara-AC) and 1-beta-D-arabinofuranosylcytosine (Ara-C) in HCT 116 colon carcinoma cells. A 3-h exposure to 0.5 microM CPE-C depleted CTP pools by over 90% and decreased dCTP pools by 57%; the effect on CTP pools persisted for up to 24 h following washout of CPE-C. A 3-h pre-exposure to 0.5 microM CPE-C augmented the growth inhibition resulting from a 24-h exposure to Ara-AC. The combination of 1 microM cytidine and deoxycytidine fully reversed the enhancement associated with CPE-C pretreatment, to a level of growth inhibition expected from either CPE-C or Ara-AC alone. A striking enhancement of toxicity was observed in clonogenic studies with pre-exposure to CPE-C at a nonlethal dose followed by either Ara-AC or Ara-C. CPE-C increased the formation of Ara-AC and Ara-C nucleotides by as much as 3-fold, and this was accompanied by increased incorporation of the arabinosyl nucleotides into methanol-precipitable material. Analysis of purified RNase-treated nucleic acids by cesium sulfate density centrifugation confirmed that a 3-h pre-exposure to CPE-C increased [3H]-Ara-C incorporation into DNA at 4 and 24 h by 2.4- and 2.7-fold, respectively. Thus, these studies indicate that CPE-C can function as a biochemical modulator. Following a brief exposure to a nonlethal concentration, CPE-C is capable of augmenting the cytotoxicity and intracellular metabolism of Ara-AC and Ara-C.
AuthorsJ L Grem, C J Allegra
JournalCancer research (Cancer Res) Vol. 50 Issue 22 Pg. 7279-84 (Nov 15 1990) ISSN: 0008-5472 [Print] United States
PMID1699659 (Publication Type: Journal Article)
Chemical References
  • Antimetabolites, Antineoplastic
  • DNA, Neoplasm
  • Deoxycytosine Nucleotides
  • Cytarabine
  • 2'-deoxycytidine 5'-triphosphate
  • fazarabine
  • Cytidine Triphosphate
  • Azacitidine
Topics
  • Antimetabolites, Antineoplastic (administration & dosage, toxicity)
  • Azacitidine (metabolism, toxicity)
  • Cell Survival (drug effects)
  • Colorectal Neoplasms (pathology)
  • Cytarabine (metabolism, toxicity)
  • Cytidine Triphosphate (metabolism)
  • DNA, Neoplasm (metabolism)
  • Deoxycytosine Nucleotides (metabolism)
  • Humans
  • In Vitro Techniques
  • Tumor Cells, Cultured (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: